In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
As of 2025, nearly 100 peptide-based drugs have received regulatory approval worldwide, with more than 200 in active clinical development
You can select any brand from the top 10 methylcobalamin injection brands in India according to your businesss needs and budget
BioMed research international, 2015(1), 648108
Your Next Steps Advances in regenerative medicine are opening new possibilities for supporting cellular health and metabolic performance
Assess your response for 1 to 2 weeks before deciding if the new dose is tolerable